Posts filtered by tags: Colorectal Cancer[x]


 

Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More

While all eyes in the biopharmaceutical world are currently trained on Bristol-Myers Squibb’s proposal to buy Celgene for $74 billion, it wasn’t that long ago that another company’s gaze was fixed on the Summit, NJ, drug maker.In the early 2000s, before the FDA approved Celgene’s flagship multiple myeloma drug lenalidomide (Revlimid), Novartis (NYSE: NVS considered buying the company. It passed, unwilling to risk billions on an unapproved drug. Those details came from biopharma dealmaker George...
Tags: Deals, Startups, China, Ipo, Cancer, Trends, Investing, Merck, Colorectal Cancer, Multiple Sclerosis, Harvard University, Health Insurance, Astrazeneca, Center For Medicare And Medicaid Services, Fda, National


Exact Sciences Acquires San Diego Lab Equipment Supplier Biomatrica

Exact Sciences has gone from being a customer of Biomatrica, a San Diego-based vendor of equipment for storing and preserving blood and saliva samples, to now being the company’s owner.Madison, WI-based Exact (NASDAQ: EXAS), which is developing diagnostic tests for several types of cancer, said Thursday that it has acquired Biomatrica for an undisclosed sum.Biomatrica manufactures and sells tools for preserving biological samples. These include circulating tumor DNA, cells, and other biomarkers...
Tags: Deals, Startups, Cancer, Trends, Vc, Colorectal Cancer, Lung Cancer, San Diego, M&a, Wisconsin, Life Sciences, Acquisitions, National blog main, San Diego blog main, San Diego top stories, Wisconsin blog main


Exact Sciences Shares Rise After Company Unveils Pfizer Partnership

Exact Sciences has recently been ramping up its efforts to market Cologuard, the company’s flagship diagnostic test that screens patients for colorectal cancer.Since the start of 2017, Madison, WI-based Exact has brought on recording artist Harry Connick Jr. and pro golfer Jerry Kelly as spokesmen, and announced a partnership with the NFL’s Green Bay Packers to promote Cologuard.Now, Exact says it plans to make what will likely be the company’s biggest—and most expensive—push to get Cologuard o...
Tags: Deals, Cancer, NFL, Trends, Colorectal Cancer, Healthcare, Wisconsin, Green Bay Packers, Pfizer, Biotech, Life Sciences, Harry Connick Jr, Baird, National blog main, New York blog main, New York top stories


Exact Sciences, Harley, Frontdesk & More: This Week’s WI Watchlist

Catch up on news from Wisconsin innovation’s community with these recent headlines:—Exact Sciences said Wednesday that it completed a lower number of its flagship diagnostic test, which screens patients test for colorectal cancer, during the three-month period ended June 30 than it had projected previously. The announcement sent shares in the Madison-based company lower in trading Thursday.Exact (NASDAQ: EXAS) said that in the second quarter, it completed about 215,000 tests of Cologuard, an at...
Tags: Deals, Startups, Kaiser Permanente, Cancer, Trends, Vc, Colorectal Cancer, Motorcycles, Electric Vehicles, Healthcare, Wisconsin, Airbnb, Biotech, Adorable, Madison, Stella


Foxconn, Data Science, Roche & More: This Week’s Wisconsin Watchlist

The collective eyes of Wisconsin’s business and technology communities are focused on a groundbreaking ceremony that Foxconn, a Taiwan-based electronics manufacturing giant, plans to hold Thursday at the site of its future electronic display production facility in the state’s southeastern corner. President Donald Trump and other big-name politicians like House Speaker Paul Ryan and Wisconsin Gov. Scott Walker reportedly plan to attend the ceremony, along with Foxconn chairman Terry Gou. F...
Tags: Deals, Startups, Layoffs, Ge, Trends, Taiwan, Vc, Diabetes, Colorectal Cancer, Lung Cancer, House, Data Science, Wisconsin, Paul ryan, Scott Walker, Bird


Exact Sciences Seeks Up to $190M in Latest Stock Offering

Exact Sciences said Friday that it plans to raise up to $190 million through the sale of notes that can be converted into cash or shares of the company’s stock, starting in 2025. Madison, WI-based Exact (NASDAQ: EXAS) is developing several screening tests for cancer patients. Its flagship product is Cologuard, a non-invasive, stool-based DNA test for colorectal cancer. The conversion price of $75.43 a share represents a premium of nearly 20 percent more than Exact’s closing share price of...
Tags: Deals, Cancer, Trends, Colorectal Cancer, Healthcare, Wisconsin, SEC, Biotech, Securities And Exchange Commission, Life Sciences, National blog main, Wisconsin blog main, Wisconsin top stories, Cologuard, Exact Sciences, EXAS


Motivo, Rockwell, Snippet & More: This Week’s Wisconsin Watchlist

Keep up with news from Wisconsin’s innovation community with these recent headlines: —Motivo, a New Berlin-based company that sells wheeled, collapsible walkers for people who need help with mobility and balance, said it raised $950,000 from investors to ramp up sales of its Motivo Tour Walker product line. The walkers, which are currently available for pre-order on the company’s website, come in a variety of styles and start at $499. Motivo said its Series A funding round was led by Just...
Tags: Deals, Startups, Internet Of Things, Milwaukee, Trends, E-commerce, Vc, Colorectal Cancer, Epic, Wisconsin, Iot, HRC, Game Shows, Gravy, Livestreaming, Machines


Exact Sciences CEO Conroy Talks Growth, Foxconn, Startups & More

Kevin Conroy left a law firm job in his early 30s, right after he had just made partner, to work for a venture capital-backed startup in California called Outcomes. The outcome was not what Conroy had hoped. About a year later, the business ran out of money and went bust. Even so, Conroy, now the 51-year-old president and CEO of Exact Sciences (NASDAQ: EXAS) never considered leaving the world of company-building to reenter the legal field. “I think opening up a hot dog stand would be more...
Tags: Startups, California, Cancer, Trends, Colonoscopy, Colorectal Cancer, Lung Cancer, Healthcare, Wisconsin, Biotech, Foxconn, Mayo Clinic, Life Sciences, Liquid Biopsy, Marquette University, Conroy


Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer

Revolution Medicines emerged three years ago to develop drugs from products found in nature and said its lead prospect would be an antifungal compound. Redwood City, CA-based Revolution is now focused on cancer and has raised $56 million to bring a completely different drug into clinical studies. The firm is targeting an enzyme called SHP2, which scientists have found plays a role in many diseases, including cancer. CEO Mark Goldsmith (pictured above) says SHP2 regulates a pathway that su...
Tags: Startups, Cancer, San Francisco, Trends, Investing, Colorectal Cancer, Fda, Biotech, Melanoma, Life Sciences, Clinical Trials, University of California San Francisco, Casdin Capital, REVOLUTION Medicines, Redwood City CA, National blog main


Exact, Spectrum, PerBlue, & More: This Week’s Wisconsin Watchlist

It was a newsy week for Wisconsin’s innovation community. Catch up on some of the major happenings with these recent headlines: —Exact Sciences’ (NASDAQ: EXAS) stock price finished the trading day on Wednesday down nearly 10 percent after the American Society of Clinical Oncology (ASCO) announced the results of a new study evaluating a liquid biopsy test for colorectal cancer. The study showed the test was up to 88 percent accurate, ABSCO said. Madison-based Exact’s flagship product is Co...
Tags: Deals, Startups, Abc, Disney, Barack Obama, Trends, Taiwan, Vc, Colorectal Cancer, Wisconsin, Benchmark, Shark Tank, Nordic, Uw-madison, Clinical Trials, ASCO


World Vegan Day: 5 Vegan Diet Health Benefits

In celebration of World Vegan Day, here are 5 science-based health benefits of a vegan diet. Read the rest of the story... »
Tags: Health, Eggs, Aging, Events, Vegetables, Fruits, Prostate Cancer, Blood Pressure, Heart Disease, Colorectal Cancer, Fiber, Type 2 Diabetes, Bmi, Body Mass Index, Pancreatic Cancer, Vegan


40% of Cancers Are Linked to Being Overweight

The rate of new cancer cases has decreased in the United States since the 1990s. But increases in overweight- and obesity-related cancers—which now account for 40% of all U.S. cancers—are likely slowing that progress, according to a new report from the Centers for Disease Control and Prevention (CDC). In 2014, about 630,000 Americans were diagnosed…
Tags: News, Breast Cancer, Obesity, Cancer, Uncategorized, Weight Loss, Overweight, Colorectal Cancer, United States, Centers for Disease Control and Prevention CDC, Meningioma, Colon Cancer, Liver Cancer, Myeloma, Kidney Cancer, Healthytime


Probiotics may help to prevent and treat colon cancer

A new study looks at the effect of Lactobacillus reuteri, a probiotic, on colon cancer development. In mice, it reduced tumor growth and inflammation.
Tags: Colorectal Cancer, Lactobacillus


Medical News Today: Probiotics may help to prevent and treat colon cancer

A new study looks at the effect of Lactobacillus reuteri, a probiotic, on colon cancer development. In mice, it reduced tumor growth and inflammation.
Tags: Colorectal Cancer, Lactobacillus


Medical News Today: Whole grains may prevent colorectal cancer

A new, large-scale report finds that whole grains significantly lower the risk of colorectal cancer, while red meat increases it.
Tags: Colorectal Cancer


Whole grains may prevent colorectal cancer

A new, large-scale report finds that whole grains significantly lower the risk of colorectal cancer, while red meat increases it.
Tags: Colorectal Cancer


Medical News Today: Bacterium promotes colorectal tumor growth

New research shows that a bacterium actively drives the growth of cancer cells in colorectal cancer. The findings may, in the future, improve treatment.
Tags: Colorectal Cancer


Exact, Microscopy, FairSquare, & More: This Week’s WI Watchlist

Keep up with the latest news from Wisconsin’s innovation community with these recent headlines: —Exact Sciences is evaluating two potential sites where it would house a second lab for processing results of its flagship product Cologuard, a stool-based DNA test for colorectal cancer, the Wisconsin State Journal reported. Madison-based Exact (NASDAQ: EXAS) said it completed 244,000 tests of Cologuard in 2016, and this year. One of the sites the company is reportedly considering used to be...
Tags: Deals, Startups, Trends, Vc, Colorectal Cancer, Epic, Stem Cells, Wisconsin, National Institutes of Health, Fda, Algorithms, Nih, Madison, Uw-madison, National Science Foundation, SPB


How does a high-fat diet raise colorectal cancer risk?

A high-fat diet is linked to a greater risk of colorectal cancer. Now, researchers believe they have found a molecular explanation for this association.
Tags: Colorectal Cancer


Medical News Today: How does a high-fat diet raise colorectal cancer risk?

A high-fat diet is linked to a greater risk of colorectal cancer. Now, researchers believe they have found a molecular explanation for this association.
Tags: Colorectal Cancer


Medical News Today: Colorectal cancer: Adding SIRT to chemotherapy boosts survival

For patients with advanced colorectal cancer, new research suggests that adding selective internal radiation therapy to chemotherapy may prolong survival.
Tags: Colorectal Cancer


Colorectal cancer: Adding SIRT to chemotherapy boosts survival

For patients with advanced colorectal cancer, new research suggests that adding selective internal radiation therapy to chemotherapy may prolong survival.
Tags: Colorectal Cancer


Parts of Mediterranean diet shown to prevent colorectal cancer

A new study highlights the specific elements of the Mediterranean diet that are the most important for keeping colorectal cancer at bay.
Tags: Colorectal Cancer, Mediterranean


Medical News Today: Parts of Mediterranean diet shown to prevent colorectal cancer

A new study highlights the specific elements of the Mediterranean diet that are the most important for keeping colorectal cancer at bay.
Tags: Colorectal Cancer, Mediterranean


Grape extracts may protect against colon cancer

A new study examines the effect of grape compounds in mice and human cells. The compounds suppress cancer stem cells, which may drive cancerous tumors.
Tags: Colorectal Cancer


Medical News Today: Grape extracts may protect against colon cancer

A new study examines the effect of grape compounds in mice and human cells. The compounds suppress cancer stem cells, which may drive cancerous tumors.
Tags: Colorectal Cancer


Array Lands $31M in Licensing Deal with Japan’s Ono Pharma

Array BioPharma has agreed to license some rights to two of its clinical-stage cancer drugs to Ono Pharmaceutical, a deal that pays the Boulder, CO, biotech $31.6 million now and potentially more if those drugs hit key milestones. Ono, based in Osaka, Japan, gains development and commercialization rights in Japan and South Korea for binimetinib, a skin cancer drug, and encorafenib, a colorectal cancer drug. Under the agreement, Array (NASDAQ: ARRY) will keep rights to commercialize both d...
Tags: Deals, Startups, South Korea, Japan, Cancer, Israel, Trends, Colorectal Cancer, Novartis, Biotech, Melanoma, Life Sciences, Clinical Trials, Ono, Osaka Japan, Boulder CO


Tree nuts may lower risk of colon cancer recurrence, death

Eating at least 2 ounces of tree nuts every week could reduce the chance of cancer recurrence and death for colon cancer patients, study suggests.
Tags: Colorectal Cancer


Medical News Today: Tree nuts may lower risk of colon cancer recurrence, death

Eating at least 2 ounces of tree nuts every week could reduce the chance of cancer recurrence and death for colon cancer patients, study suggests.
Tags: Colorectal Cancer


Researchers issue first predictive risk model of colon, rectal cancer based on data from Spanish population

Researchers of the Colorectal Cancer research group of Bellvitge Biomedical Research Institute, led by Dr. Víctor Moreno, and linked to the Catalan Institute of Oncology, the University of Barcelona and the Epidemiology and Public Health CIBER, have issued the first predictive risk model of colon and rectal cancer based on Spanish data that combines genetic and lifestyle information.
Tags: Health, Colorectal Cancer, Bellvitge Biomedical Research Institute, Víctor Moreno, Epidemiology and Public Health CIBER